Investorideas.com
Search  Follow Investorideas on Twitter  Investorideas is on Facebook  Investorideas is on Google Plus  Investorideas is on Youtube  Investorideas is on Pinterest  Investorideas is on tumblr  Investorideas is on LinkedIn  Investorideas RSS 


Investorideas podcasts on iTunes, Google Play Music and iHeart.com    Bitcoin and Blockchain Stocks    Play by Play – the latest sports headlines and sports stock news

 

Join Investor Ideas Members to access the Renewable Energy stocks directory, water stocks, biotech stocks, defense stocks directories and the Insiders Corner

Marijuana Companies & Investors from the U.S. and Canada Plot Next Moves In Vancouver April 30 - May 2

1st NASDAQ-traded company CEO Mike Gorenstein of Cronos Group and most pro-cannabis Republican, Congressman Dana Rohrabacher to address group; Dozens of Promising Cannabis Companies Pitch Investors in ‘Shark-Tank' Style Format

 

Vancouver, BC - April 27, 2018 (Investorideas.com Newswire) On the heels of Trump backing states' rights on marijuana and former Speaker of the House John Boehner joining the cannabis industry, more than 200 high-net worth investors from around the world will gather at The Westin Bayshore for a two-day forum on Tuesday, May 1st and Wednesday, May 2nd, hosted for members of The Arcview Investor Network. High net worth accredited investors will be reviewing pitches from companies who competed fiercely for a slot out of a field of hundreds of applicants. In 2017 alone, Arcview's members placed more than $50 million in 60+ Arcview-curated companies, making them the top source of capital for the cannabis industry.

Mike Gorenstein, CEO of the Cronos Group, will deliver a keynote speech. Cronos, owner of numerous licensed cannabis producers in Canada, recently became the sector's first company listed on a major U.S. exchange, and promptly raised $100 million. Congressman Dana Rohrabacher, the most pro-cannabis Republican in Congress and co-sponsor of the Rohrabacher–Farr amendment prohibiting the Justice Department from spending funds to interfere with the implementation of state medical cannabis laws, will also be addressing this group of industry leaders.

"In a few months, Canada will become the first G7 country to legalize cannabis. Investors have responded, pouring money into the sector and sending the stock prices of Canadian companies into the stratosphere. Now flush with cash, Canadian-listed companies are looking beyond the modestly-sized Canadian market for global opportunities, and turning their attention to the capital-constrained U.S. market. News of the President and top Republicans changing their tune on cannabis is adding to the excitement around the possibility of a rapid change in U.S. federal law," said Troy Dayton, CEO and co-Founder of The Arcview Group.

Learn more about the growth of the cannabis industry via this short video. To get a sense of what to expect at Arcview, see this short video.

  • Who: Members of The Arcview Investor Network plus cannabis-related companies chosen to present.
  • What: Select media representatives will be invited to witness presentations from companies that have been successful at raising capital from this group and those who are hoping to attract investors at this meeting. Throughout the day, select reporters will be able to interview high net worth investors who have recently invested in the sector or are considering it, companies that have recently been funded, and elected officials that support legalization.
  • When: Tuesday, May 1st and Wednesday, May 2nd between 9:30AM – 4:00PM.
  • Where: The Westin Bayshore, 1601 Bayshore Drive, Vancouver, BC, Canada.
  • How: Members of the media must apply for press credentials by emailing abbybenjamin@arcviewgroup.com.

About The Arcview Group

Founded in 2010, The Arcview Group is responsible for a number of groundbreaking ventures in the cannabis industry. The Arcview Investor Network includes more than 600 accredited investors who have put more than $160 million behind 170+ companies. Arcview Market Research publishes the State of Legal Marijuana Markets report, which is the most oft-cited market data report. In 2015 Arcview became a partner in Canopy, the first seed-stage mentor-driven business accelerator. Arcview is also co-founder of Cannasure Insurance Services, the leading provider of business insurance to the cannabis industry.

Some of the people expected to attend and available for interviews include:

Mike Gorenstein, CEO of Cronos Group, a globally-diversified and vertically-integrated cannabis company with a presence across four continents.

Congressman Dana Rohrabacher (R-CA), co-sponsor of the Rohrabacher–Farr amendment, which prohibits the Justice Department from spending funds to interfere with the implementation of state medical cannabis laws.

Steve DeAngelo, Executive Director of Harborside Health Centers, star of Discovery Channel's hit show Weed Wars, author of the book The Cannabis Manifesto, co-Founder and President of The Arcview Group, and co-Founder of the first cannabis testing lab, Steep Hill.

Troy Dayton, co-Founder and CEO of The Arcview Group, Board Member of the Marijuana Policy Project and the National Cannabis Industry Association, and co-Founder of Students for Sensible Drug Policy. Named by Fortune Magazine, International Business Times, and Details Magazine in their lists of most influential people in the cannabis industry.

Cassandra Farrington, CEO of Marijuana Business Daily, the top media and trade show company in the cannabis sector. Named to the Inc. 5000 and named in the top 5 fastest growing trade shows in North America.

Alan Gertner, CEO of Hiku Brands, a company whose valuation grew from $4M two years ago to a current market cap in excess of CAD $350 million. Alan is a former Google executive.

Sturges Karban, CEO of MJIC, a California infrastructure network to move cannabis state-wide, legally. He has expertise across cannabis, investment banking, real estate and entertainment, and is regularly featured in major media outlets.

Neil Closner, CEO of MedReleaf, co-founded and organically grew the company into the country's second largest Licensed Producer with just under a 20% share of the medical cannabis market. Neil is also Chairman of the Board of the Cannabis Canada Association, representing the majority of Licensed Producers.

Greg Engel, CEO of Organigram Holdings Inc., a licensed Canadian producer of medical cannabis. Greg has more than 30 years of experience in pharma, biotech, and CPG and has overseen Organigram's 50% share price gain in his two-year tenure.

Michael Ray, Founder/CEO of Bloom Farms, a California-based cannabis lifestyle brand and distribution company with products sold in hundreds of retail locations throughout California and Nevada.

Michael Elkin, Vice President of Cannabis Compliance Inc., a global cannabis-focused compliance consulting firm representing over 125 active applications for cannabis production with the Canadian government.

Jeanne Sullivan, co-Founder of StarVest Partners, a venture capital firm in NYC, and long time tech investor. Cited by Forbes as "one of the women venture capitalists changing the world - grooming the next generation of female entrepreneurs."

Anthony Dutton, CEO of CannEx Capital Holdings, a Vancouver, BC-based firm providing real estate, management, financial, branding, and IP services to licensed cannabis businesses. CannEx recently acquired Jetty Extracts, a California-based cannabis extraction and processing facility.

Vahan Ajamian, Equity Analyst at Beacon Securities. Positioned at the intersection of institutional capital, IPOs, M&A, and industry-wide policy, Vahan deeply understands the Canadian cannabis market.

Myrna Gillis, CEO of Aqualitas, a licensed Canadian cultivator that raised millions from Arcview members.

Lindsay Robinson, Executive Director of the California Cannabis Industry Association. Most recently, CCIA was instrumental in passing the Governor's trailer bill, which reconciled the state medical marijuana and adult-use frameworks.

John Brecker and Rod Stephan, Partners at Altitude Investment Management, a cannabis-focused venture capital firm overseeing investments in ancillary businesses as well as enterprises which touch the plant.

Patrick Rea, Managing Director of Canopy, a seed-stage, mentor-driven business accelerator partnered with Arcview, and serving the cannabis industry since 2014.

Tom Adams, Editor-In-Chief of Arcview Market Research, and lead researcher for the soon to be released 6th edition of The State of Legal Marijuana Markets co-produced with BDS Analytics. Tom has projected the growth curves for a number of business booms over the last few decades.

Event sponsors include: MJIC, Electrum Partners, MassRoots, Marijuana Business Daily, MedPharm Holdings, Choom, Electrum Partners, Inner Spirit Holdings, Deepwater, Cannabis Compliance Inc., TenX Ventures Inc., Steep Hill, Marijuana Policy Project, New Frontier Data, I-nvention, CannEx Capital, Organigram, Ravenquest Biomed Inc., Beacon Securities, Austin Legal Group, Glorietta Management Group, Thai Cannabis Corp., Phylos Biosciences, Province Brands, Convectium, Altopa, Aqualitas, Canopy Boulder, BDS Analytics



Marijuana / Hemp Stocks

Marijuana / Hemp Stocks

At Cannabisinvestorideas.com and Investorideas.com

Like Marijuana / Hemp Stocks? View our Marijuana / Hemp Stocks Directory

Join our Group on Linkedin - Marijuana / Hemp Stocks - News and Trends in Green Investing

Also check out our AI blog Global Cannabis Investing - features Investor Ideas Cannabis news


More Info:

Investorideas.com Newswire

This news is published on the Investorideas.com Newswire - a global digital news source for investors and business leaders

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release on the Investorideas.com newswire http://www.investorideas.com/News-Upload/

Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.